Literature DB >> 8203950

Humoral immune response against minor collagens type IX and XI in patients with cartilage graft resorption after reconstructive surgery.

J Bujia1, S Alsalameh, A Naumann, E Wilmes, M Sittinger, G R Burmester.   

Abstract

OBJECTIVES: The humoral immune response against a broad spectrum of cartilage antigens (cellular and matrix antigens) was studied in a group of patients who showed resorption and/or rejection of transplanted cartilage in nasal surgery.
METHODS: Sera were obtained from patients with successful and unsuccessful cartilage grafting in the nose, from age and sex-matched healthy donors and from patients with rheumatoid arthritis. Antibodies to cartilage components were analysed by the following methods: (1) indirect immunofluorescence on cartilage sections, (2) ELISA using cultured human chondrocytes, isolated chondrocyte membranes and purified collagens type I, II, III, VI, IX and XI, and (3) immunoblotting with purified collagens and chondrocyte cell membranes.
RESULTS: In the cartilage grafting group showing resorption problems, levels of anti-collagen antibodies were significantly higher against native collagen types IX (p < 0.002) and XI (p < 0.002) compared with the non-resorption group and the normal donors. Both transplantation groups revealed elevated reactivities against isolated chondrocytes in the ELISA. In contrast, no reactivity was detectable against collagens type II, III, and VI and chondrocyte cell membranes by both ELISA and immunoblotting.
CONCLUSIONS: These data demonstrate for the first time the existence of a humoral immune response, primarily directed against the so called 'minor cartilage collagens', in patients showing cartilage resorption. Autoreactivities to collagen which are typical of inflammatory rheumatic diseases may also play an important role in the repeated failure of cartilage grafting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203950      PMCID: PMC1005300          DOI: 10.1136/ard.53.4.229

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

Review 1.  Immunobiology of cartilage.

Authors:  J H Herman; B A Carpenter
Journal:  Semin Arthritis Rheum       Date:  1975-08       Impact factor: 5.532

2.  Some studies on the antigenicity of cartilage.

Authors:  E E PEACOCK; P M WEEKS; J M PETTY
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

3.  Collagen heterogeneity in human cartilage: identification of several new collagen chains.

Authors:  R E Burgeson; D W Hollister
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

4.  The auto-immunogenicity of articular cartilage.

Authors:  F Langer; A E Gross; M F Greaves
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

5.  Enzymatic events during cartilage differentiation in the chick embryonic limb bud.

Authors:  J Medoff
Journal:  Dev Biol       Date:  1967-08       Impact factor: 3.582

6.  The significance of the intercellular matrix in the survival of cartilage allografts.

Authors:  S Heyner
Journal:  Transplantation       Date:  1969-11       Impact factor: 4.939

7.  Induction of cell-mediated immunity and tolerance to homologous collagen in guinea pigs: demonstration of antigen-reactive cells for a self-antigen.

Authors:  G Senyk; D Michaeli
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Experiences with the use of lyophilized bank cartilage for facial contour correction.

Authors:  H F Sailer
Journal:  J Maxillofac Surg       Date:  1976-05-01

10.  Antibodies to type II collagen in relapsing polychondritis.

Authors:  J M Foidart; S Abe; G R Martin; T M Zizic; E V Barnett; T J Lawley; S I Katz
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

View more
  8 in total

1.  Expression of ICAM-1 on intact cartilage and isolated chondrocytes.

Authors:  J Bujia; U Behrends; N Rotter; P Pitzke; E Wilmes; C Hammer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-02       Impact factor: 2.416

2.  Antibodies to collagens in sera from patients receiving bovine cartilage graft.

Authors:  M Sittinger; R Jerez; G R Burmester; T Krafft; W Spitzer
Journal:  Ann Rheum Dis       Date:  1996-05       Impact factor: 19.103

3.  Extra-articular cartilage affected in collagen-induced, but not pristane-induced, arthritis models.

Authors:  A-S Hansson; S Lu; R Holmdahl
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 4.  Cartilage and bone tissue engineering for reconstructive head and neck surgery.

Authors:  Nicole Rotter; Andreas Haisch; Markus Bücheler
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-10       Impact factor: 2.503

5.  Creating artificial perichondrium by polymer complex membrane macroencapsulation: immune protection and stabilization of subcutaneously transplanted tissue-engineered cartilage.

Authors:  Andreas Haisch; Andreas Gröger; Christopher Gebert; Korinna Leder; Jörg Ebmeyer; Holger Sudhoff; Sergije Jovanovic; Benedikt Sedlmaier; Michael Sittinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-10-23       Impact factor: 2.503

Review 6.  Clinical cartilage restoration: evolution and overview.

Authors:  Jack Farr; Brian Cole; Aman Dhawan; James Kercher; Seth Sherman
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

Review 7.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

8.  Cartilage immunoprivilege depends on donor source and lesion location.

Authors:  B Arzi; G D DuRaine; C A Lee; D J Huey; D L Borjesson; B G Murphy; J C Y Hu; N Baumgarth; K A Athanasiou
Journal:  Acta Biomater       Date:  2015-05-28       Impact factor: 8.947

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.